Glut1 deficiency syndrome and erythrocyte glucose uptake assay

Annals of Neurology

Volumn 70, Issue 6, 2011, Pages 996-1005

  Yang, Hong ^a   Wang, Dong ^a   Engelstad, Kristin ^a   Bagay, Leslie ^a   Wei, Ying ^a   Rotstein, Michael ^a   Aggarwal, Vimla ^a   Levy, Brynn ^a   Ma, Lijiang ^a   Chung, Wendy K ^a   De Vivo, Darryl C ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LACTIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; GLUCOSE TRANSPORT; GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MICROCEPHALY; MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

BLOOD GLUCOSE; CHILD, PRESCHOOL; ERYTHROCYTES; FAMILY HEALTH; FEMALE; GLUCOSE TRANSPORTER TYPE 1; GUANOSINE; HUMANS; INFANT; MALE; METABOLIC DISEASES; MUTATION; ROC CURVE; SEIZURES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 84255194777     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22640     Document Type: Article

References (27)

1. Harik SI, Gravina SA, Kalaria RN,. Glucose transporter of the blood-brain barrier and brain in chronic hyperglycemia. J Neurochem 1988; 51: 1930-1934. (Pubitemid 19010986)
2. Harik SI, Kalaria RN, Andersson L, et al. Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci 1990; 10: 3862-3872.
3. De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325: 703-709.
4. Pons R, Collins A, Rotstein M, et al. The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 2010; 25: 275-281.
5. Rotstein M, Doran J, Yang H, et al. Glut1 deficiency and alternating hemiplegia of childhood. Neurology 2009; 73: 2042-2044.
6. Suls A, Dedeken P, Goffin K, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008; 131: 1831-1844. (Pubitemid 351957463)
7. Weber YG, Storch A, Wuttke TV, et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008; 118: 2157-2168. (Pubitemid 351872334)
8. Zorzi G, Castellotti B, Zibordi F, et al. Paroxysmal movement disorders in GLUT1 deficiency syndrome. Neurology 2008; 71: 146-148.
9. De Vivo DC, Wang D,. Glut1 deficiency: CSF glucose. How low is too low? Rev Neurol (Paris) 2008; 164: 877-880.
10. Levy B, Wang D, Ullner P, et al. Uncovering microdeletions in patients with severe Glut-1 deficiency syndrome using SNP oligonucleotide microarray analysis. Mol Genet Metab 2010; 100: 129-135.
11. Wang D, Pascual JM, Yang H, et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 2005; 57: 111-118. (Pubitemid 40053322)
12. Rotstein M, Engelstad K, Yang H, et al. Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol 2010; 68: 955-958.
13. De Vivo DC, Garcia-Alvarez M, Ronen GM,. Glucose transport protein deficiency: an emerging syndrome with therapeutic implications. Int Ped 1995; 10: 51-56.
14. Klepper J, Garcia-Alvarez M, O'Driscoll KR, et al. Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J Clin Lab Anal 1999; 13: 116-121. (Pubitemid 29207136)
15. Kaufmann P, Shungu DC, Sano MC, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004; 62: 1297-1302. (Pubitemid 38526040)
16. Zhou X, Obuchowski N, McClish D,. Statistical methods in diagnostic medicine. New York: Wiley; 2002.
17. Wang D, Kranz-Eble P, De Vivo DC,. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum Mutat 2000; 16: 224-231.
18. Wang D, Yang H, Shi L, et al. Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M. Pediatr Res 2008; 64: 538-543.
19. Javadekar BB, Vyas MD, Anand IS,. CSF/blood glucose ratio and other prognostic indices in pyogenic meningitis. J Indian Med Assoc 1997; 95: 9-11.
20. Saez-Llorens X, McCracken GH Jr,. Bacterial meningitis in children. Lancet 2003; 361: 2139-2148. (Pubitemid 36782263)
21. Dubos F, Moulin F, Gajdos V, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 2006; 149: 72-76. (Pubitemid 44081923)
22. Lindquist L, Linne T, Hansson LO, et al. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis 1988; 7: 374-380.
23. Silver TS, Todd JK,. Hypoglycorrhachia in pediatric patients. Pediatrics 1976; 58: 67-71.
24. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-488. (Pubitemid 14021826)
25. Fujii T, Morimoto M, Yoshioka H, et al. T295M-associated Glut1 deficiency syndrome with normal erythrocyte 3-OMG uptake. Brain Dev 2010; 33: 316-320.
26. Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133: 655-670.
27. Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE,. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 2010; 75: 432-440.